Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-15

Clinical Trial Update: Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK) [NA]

View source ↗

Summary

This entry notes the completion of a trial studying exhaled nitric oxide-guided asthma treatment (NOAK) for allergic asthma. The sponsor is Karolinska Institute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Karolinska Institutet | Conditions: Allergic Asthma | NA | Status: COMPLETED